WP1066, a JAK2 inhibitor, suppresses ovarian cancer growth, migration, and invasion; this inhibitor also enhances the chemosensitivity of ovarian cancer cells and decreases the rate of STAT3 phosphorylation90. The gene discussed is STAT3; the disease is ovarian carcinoma.